I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 121 filers reported holding I MAB in Q1 2022. The put-call ratio across all filers is 1.75 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,572 | -91.6% | 1,191 | -81.0% | 0.00% | – |
Q2 2023 | $18,714 | -13.6% | 6,259 | 0.0% | 0.00% | – |
Q1 2023 | $21,656 | -17.2% | 6,259 | 0.0% | 0.00% | – |
Q4 2022 | $26,163 | +4.7% | 6,259 | 0.0% | 0.00% | – |
Q3 2022 | $25,000 | -98.6% | 6,259 | -96.0% | 0.00% | -100.0% |
Q2 2022 | $1,779,000 | -56.0% | 157,432 | -36.7% | 0.00% | 0.0% |
Q1 2022 | $4,039,000 | -62.6% | 248,687 | +9.3% | 0.00% | -66.7% |
Q4 2021 | $10,787,000 | -4.2% | 227,616 | +46.6% | 0.00% | -25.0% |
Q3 2021 | $11,257,000 | +26.5% | 155,284 | +46.4% | 0.00% | +33.3% |
Q2 2021 | $8,901,000 | – | 106,033 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |